STRONGBRIDGE BIOPHARMA plc Long-Term Debt, Maturity, Year Three
STRONGBRIDGE BIOPHARMA plc had Long-Term Debt, Maturity, Year Three of $4.17 million as of 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree · last filed 2021-08-05
- 2021-06-30: Long-Term Debt, Maturity, Year Three $4.17M.
- 2021-03-31: Long-Term Debt, Maturity, Year Three $4.17M.
- 2020-12-31: Long-Term Debt, Maturity, Year Three $10.00M.
- 2020-09-30: Long-Term Debt, Maturity, Year Three $5.00M.
| Period end | Long-Term Debt, Maturity, Year Three |
|---|---|
| 2021-06-30 | $4.17M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $4.17M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $10.00M 10-K · filed 2021-03-03 |
| 2020-09-30 | $5.00M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $3.33M 10-Q · filed 2020-08-04 |
| 2017-12-31 | $6.83M 10-K · filed 2018-03-12 |
| 2017-06-30 | $8.00M 6-K · filed 2017-08-07 |
| 2017-03-31 | $8.00M 6-K · filed 2017-05-16 |
| 2016-12-31 | $8.00M 20-F · filed 2017-04-04 |